132 related articles for article (PubMed ID: 9871534)
1. New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone.
Edwards JP; West SJ; Pooley CL; Marschke KB; Farmer LJ; Jones TK
Bioorg Med Chem Lett; 1998 Apr; 8(7):745-50. PubMed ID: 9871534
[TBL] [Abstract][Full Text] [Related]
2. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one.
Edwards JP; Higuchi RI; Winn DT; Pooley CL; Caferro TR; Hamann LG; Zhi L; Marschke KB; Goldman ME; Jones TK
Bioorg Med Chem Lett; 1999 Apr; 9(7):1003-8. PubMed ID: 10230628
[TBL] [Abstract][Full Text] [Related]
4. Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone.
Zhi L; Tegley CM; Marschke KB; Jones TK
Bioorg Med Chem Lett; 1999 Apr; 9(7):1009-12. PubMed ID: 10230629
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of carborane-containing androgen receptor (AR) antagonist bearing a pyridine ring.
Ohta K; Goto T; Fijii S; Suzuki T; Ohta S; Endo Y
Bioorg Med Chem; 2008 Sep; 16(17):8022-8. PubMed ID: 18707892
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines.
Hamann LG; Higuchi RI; Zhi L; Edwards JP; Wang XN; Marschke KB; Kong JW; Farmer LJ; Jones TK
J Med Chem; 1998 Feb; 41(4):623-39. PubMed ID: 9484511
[TBL] [Abstract][Full Text] [Related]
7. Effects of isosteric pyridone replacements in androgen receptor antagonists based on 1,2-dihydro- and 1,2,3,4-tetrahydro-2,2-dimethyl-6-trifluoromethyl-8-pyridono[5,6-g]quin olines.
Kong JW; Hamann LG; Ruppar DA; Edwards JP; Marschke KB; Jones TK
Bioorg Med Chem Lett; 2000 Mar; 10(5):411-4. PubMed ID: 10743937
[TBL] [Abstract][Full Text] [Related]
8. Circumventing anti-androgen resistance by molecular design.
McGinley PL; Koh JT
J Am Chem Soc; 2007 Apr; 129(13):3822-3. PubMed ID: 17348658
[TBL] [Abstract][Full Text] [Related]
9. Effects of steroidal and non-steroidal antiandrogens on wild-type and mutant androgen receptors.
Urushibara M; Ishioka J; Hyochi N; Kihara K; Hara S; Singh P; Isaacs JT; Kageyama Y
Prostate; 2007 Jun; 67(8):799-807. PubMed ID: 17373727
[TBL] [Abstract][Full Text] [Related]
10. Effects of antiandrogens on transformation and transcription activation of wild-type and mutated (LNCaP) androgen receptors.
Berrevoets CA; Veldscholte J; Mulder E
J Steroid Biochem Mol Biol; 1993 Dec; 46(6):731-6. PubMed ID: 8274406
[TBL] [Abstract][Full Text] [Related]
11. Chemical Degradation of Androgen Receptor (AR) Using Bicalutamide Analog-Thalidomide PROTACs.
Kim GY; Song CW; Yang YS; Lee NR; Yoo HS; Son SH; Lee SJ; Park JS; Lee JK; Inn KS; Kim NJ
Molecules; 2021 Apr; 26(9):. PubMed ID: 33926033
[TBL] [Abstract][Full Text] [Related]
12. Activation of the human androgen receptor through a protein kinase A signaling pathway.
Nazareth LV; Weigel NL
J Biol Chem; 1996 Aug; 271(33):19900-7. PubMed ID: 8702703
[TBL] [Abstract][Full Text] [Related]
13. The discovery of a potent orally efficacious indole androgen receptor antagonist through in vivo screening.
Lanter JC; Fiordeliso JJ; Jiang W; Allan GF; Lai MT; Linton O; Hahn do W; Lundeen SG; Sui Z
Bioorg Med Chem Lett; 2007 Jan; 17(1):123-6. PubMed ID: 17071085
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones.
Zhao S; Shen Y; van Oeveren A; Marschke KB; Zhi L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3431-5. PubMed ID: 18442912
[TBL] [Abstract][Full Text] [Related]
15. Substituted 6-(1-pyrrolidine)quinolin-2(1H)-ones as novel selective androgen receptor modulators.
Martinborough E; Shen Y; Oeveren Av; Long YO; Lau TL; Marschke KB; Chang WY; López FJ; Vajda EG; Rix PJ; Viveros OH; Negro-Vilar A; Zhi L
J Med Chem; 2007 Oct; 50(21):5049-52. PubMed ID: 17887661
[TBL] [Abstract][Full Text] [Related]
16. The amino terminus of the human AR is target for corepressor action and antihormone agonism.
Dotzlaw H; Moehren U; Mink S; Cato AC; Iñiguez Lluhí JA; Baniahmad A
Mol Endocrinol; 2002 Apr; 16(4):661-73. PubMed ID: 11923464
[TBL] [Abstract][Full Text] [Related]
17. Novel selective androgen receptor modulators: SAR studies on 6-bisalkylamino-2-quinolinones.
van Oeveren A; Motamedi M; Martinborough E; Zhao S; Shen Y; West S; Chang W; Kallel A; Marschke KB; López FJ; Negro-Vilar A; Zhi L
Bioorg Med Chem Lett; 2007 Mar; 17(6):1527-31. PubMed ID: 17267219
[TBL] [Abstract][Full Text] [Related]
18. Computationally identified novel diphenyl- and phenylpyridine androgen receptor antagonist structures.
Söderholm AA; Viiliäinen J; Lehtovuori PT; Eskelinen H; Roell D; Baniahmad A; Nyrönen TH
J Chem Inf Model; 2008 Sep; 48(9):1882-90. PubMed ID: 18712859
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides.
Tucker H; Crook JW; Chesterson GJ
J Med Chem; 1988 May; 31(5):954-9. PubMed ID: 3361581
[TBL] [Abstract][Full Text] [Related]
20. Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.
He Y; Yin D; Perera M; Kirkovsky L; Stourman N; Li W; Dalton JT; Miller DD
Eur J Med Chem; 2002 Aug; 37(8):619-34. PubMed ID: 12161060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
